BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33446917)

  • 1. Pulmonary immune cell transcriptome changes in double-hit model of BPD induced by chorioamnionitis and postnatal hyperoxia.
    Shrestha D; Ye GX; Stabley D; Betal SGN; Zhu Y; Glazewski L; Holbrook J; Sethi M; Hesek A; Shaffer TH; Aghai ZH; Addya S; Alapati D
    Pediatr Res; 2021 Sep; 90(3):565-575. PubMed ID: 33446917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolome and microbiome multi-omics integration from a murine lung inflammation model of bronchopulmonary dysplasia.
    El Saie A; Fu C; Grimm SL; Robertson MJ; Hoffman K; Putluri V; Ambati CSR; Putluri N; Shivanna B; Coarfa C; Pammi M
    Pediatr Res; 2022 Dec; 92(6):1580-1589. PubMed ID: 35338351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune System Regulation Affected by a Murine Experimental Model of Bronchopulmonary Dysplasia: Genomic and Epigenetic Findings.
    Revhaug C; Bik-Multanowski M; Zasada M; Rognlien AGW; Günther CC; Ksiązek T; Madetko-Talowska A; Szewczyk K; Grabowska A; Kwinta P; Pietrzyk JJ; Baumbusch LO; Saugstad OD
    Neonatology; 2019; 116(3):269-277. PubMed ID: 31454811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia.
    Nold MF; Mangan NE; Rudloff I; Cho SX; Shariatian N; Samarasinghe TD; Skuza EM; Pedersen J; Veldman A; Berger PJ; Nold-Petry CA
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14384-9. PubMed ID: 23946428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung omics signatures in a bronchopulmonary dysplasia and pulmonary hypertension-like murine model.
    Shrestha AK; Gopal VYN; Menon RT; Hagan JL; Huang S; Shivanna B
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L734-L741. PubMed ID: 30047283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-resolved transcriptomic profiling of the developing rabbit's lungs: impact of premature birth and implications for modelling bronchopulmonary dysplasia.
    Storti M; Faietti ML; Murgia X; Catozzi C; Minato I; Tatoni D; Cantarella S; Ravanetti F; Ragionieri L; Ciccimarra R; Zoboli M; Vilanova M; Sánchez-Jiménez E; Gay M; Vilaseca M; Villetti G; Pioselli B; Salomone F; Ottonello S; Montanini B; Ricci F
    Respir Res; 2023 Mar; 24(1):80. PubMed ID: 36922832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia.
    Seedorf G; Kim C; Wallace B; Mandell EW; Nowlin T; Shepherd D; Abman SH
    Am J Respir Crit Care Med; 2020 May; 201(9):1120-1134. PubMed ID: 32101461
    [No Abstract]   [Full Text] [Related]  

  • 8. Bronchopulmonary dysplasia in a double-hit mouse model induced by intrauterine hypoxia and postnatal hyperoxia: closer to clinical features?
    Gortner L; Monz D; Mildau C; Shen J; Kasoha M; Laschke MW; Roolfs T; Schmiedl A; Meier C; Tutdibi E
    Ann Anat; 2013 Jul; 195(4):351-358. PubMed ID: 23684450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal mesenchymal stromal cell extracellular vesicle treatment preserves lung development in a model of bronchopulmonary dysplasia due to chorioamnionitis.
    Abele AN; Taglauer ES; Almeda M; Wilson N; Abikoye A; Seedorf GJ; Mitsialis SA; Kourembanas S; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2022 Feb; 322(2):L179-L190. PubMed ID: 34878940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chorioamnionitis is essential in the evolution of bronchopulmonary dysplasia--the case in favour.
    Thomas W; Speer CP
    Paediatr Respir Rev; 2014 Mar; 15(1):49-52. PubMed ID: 24128984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the expression profiles and functions of circRNAs in a newborn hyperoxia-induced rat bronchopulmonary dysplasia model.
    Cheng H; Wu B; Wang L; Hu T; Deng Z; Li D
    J Gene Med; 2020 May; 22(5):e3163. PubMed ID: 31961470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of long non-coding RNAs in hyperoxia-induced bronchopulmonary dysplasia.
    Bao TP; Wu R; Cheng HP; Cui XW; Tian ZF
    Cell Biochem Funct; 2016 Jul; 34(5):299-309. PubMed ID: 27137150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary vascular disease is evident in gene regulation of experimental bronchopulmonary dysplasia.
    Revhaug C; Zasada M; Rognlien AGW; Günther CC; Grabowska A; Książek T; Madetko-Talowska A; Szewczyk K; Bik-Multanowski M; Kwinta P; Pietrzyk JJ; Baumbusch LO; Saugstad OD
    J Matern Fetal Neonatal Med; 2020 Jun; 33(12):2122-2130. PubMed ID: 30428746
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting glycogen synthase kinase-3β to prevent hyperoxia-induced lung injury in neonatal rats.
    Hummler SC; Rong M; Chen S; Hehre D; Alapati D; Wu S
    Am J Respir Cell Mol Biol; 2013 May; 48(5):578-88. PubMed ID: 23328640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Leukadherin-1 in the Prevention of Hyperoxia-Induced Lung Injury in Neonatal Rats.
    Jagarapu J; Kelchtermans J; Rong M; Chen S; Hehre D; Hummler S; Faridi MH; Gupta V; Wu S
    Am J Respir Cell Mol Biol; 2015 Dec; 53(6):793-801. PubMed ID: 25909334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRF4 affects the protective effect of regulatory T cells on the pulmonary vasculature of a bronchopulmonary dysplasia mouse model by regulating FOXP3.
    Zhu Y; He L; Zhu Y; Yao H; Jiang J; Lu H
    Mol Med; 2024 Jan; 30(1):6. PubMed ID: 38195465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte-Specific Biomarkers Associated With Preterm Birth and Bronchopulmonary Dysplasia.
    Bhattacharya S; Mereness JA; Baran AM; Misra RS; Peterson DR; Ryan RM; Reynolds AM; Pryhuber GS; Mariani TJ
    Front Immunol; 2020; 11():563473. PubMed ID: 33552042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus plantarum L168 improves hyperoxia-induced pulmonary inflammation and hypoalveolarization in a rat model of bronchopulmonary dysplasia.
    Shen X; Yang Z; Wang Q; Chen X; Zhu Q; Liu Z; Patel N; Liu X; Mo X
    NPJ Biofilms Microbiomes; 2024 Mar; 10(1):32. PubMed ID: 38553470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesfatin-1 alleviates hyperoxia-induced bronchopulmonary dysplasia (BPD) via the nuclear factor-κB (NF-κB) p65 signaling pathway.
    Zhang L; Zhuo Z; Chen L; Liu J; Huang J; Deng J; Lu W; Jiang X
    J Biochem Mol Toxicol; 2024 Apr; 38(4):e23680. PubMed ID: 38511245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease.
    Reynolds CL; Zhang S; Shrestha AK; Barrios R; Shivanna B
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1597-605. PubMed ID: 27478373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.